Dear Sir/Madam, Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015, please find attached the certificate issued by RTA. Thanking ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has filed its quarterly investor complaints report with BSE and MSE as required under SEBI Listing Regulations. The report covers the quarter ending 31 December 2025 and was certified by the company's Registrar and Transfer Agent, Purva Sharegistry (India) Pvt Ltd. The company reported zero investor complaints across all categories — none were pending at the start of the quarter, none were received during the quarter, none were disposed of, and none remained unresolved at the end. The filing was signed by Director Ravender Singh (DIN: 09447213) and is a routine compliance submission with no new operational or financial information.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. The clean complaint record reflects standard investor grievance handling but does not signal any positive or negative change in the business.